Kirkland Advises GTCR-Backed Corza Medical on Divestiture of Biosurgery Business Unit to EQT
July 07, 2026
July 07, 2026
CHICAGO, Illinois, July 7 [Category: BizLaw/Legal] -- Kirkland and Ellis, a law firm, issued the following news release:
* * *
Kirkland Advises GTCR-Backed Corza Medical on Divestiture of Biosurgery Business Unit to EQT
*
Kirkland represented GTCR-backed Corza Medical, a leading global medical technology company, on its agreement to sell its Biosurgery business unit, including the TachoSil(r) product portfolio, to EQT. Financial terms of the ag . . .
* * *
Kirkland Advises GTCR-Backed Corza Medical on Divestiture of Biosurgery Business Unit to EQT
*
Kirkland represented GTCR-backed Corza Medical, a leading global medical technology company, on its agreement to sell its Biosurgery business unit, including the TachoSil(r) product portfolio, to EQT. Financial terms of the ag . . .